Clinical Trial Update: Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial sponsored by Icahn School of Medicine at Mount Sinai is evaluating cannabinoids to reduce inflammation and sickle cell-related pain; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Sickle Cell Disease | Phase 2 | Status: RECRUITING